Pharmaceutical composition for treating idiopathic pulmonary fibrosis and application of such pharmaceutical composition
A technology for pulmonary fibrosis and a composition is applied in the field of pharmaceutical compositions for the treatment of idiopathic pulmonary fibrosis, which can solve the problems of large toxic and side effects, poor treatment effect, etc., and achieves no toxic and side effects, wide application value, and difficulty in recurrence. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0015] In the embodiment of the present invention, a pharmaceutical composition for treating idiopathic pulmonary fibrosis is composed of nafamostat and artesunate, wherein the mass ratio of nafamostat and artesunate is 1.6:1.
Embodiment 2
[0017] In the embodiment of the present invention, a pharmaceutical composition for treating idiopathic pulmonary fibrosis is composed of nafamostat and artesunate, wherein the mass ratio of nafamostat and artesunate is 2.4:1.
Embodiment 3
[0019] In the embodiment of the present invention, a pharmaceutical composition for treating idiopathic pulmonary fibrosis is composed of nafamostat and artesunate, wherein the mass ratio of nafamostat and artesunate is 1.8:1.
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com